- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Danish pharmaceuticals maker is facing tighter margins and tougher competition in the U.S.
Gainers include ArcelorMittal, Lafargeholcim, Nokia, Maersk
UnitedHealth becomes the second major healthcare provider to scratch the insulin product from its 2017 medicines roster.
Allegations that Merck breached patents on diabetes blockbuster Lantus looks like a replay of Sanofi's 2015 case against Eli Lilly.